This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Why economic indicators matter to investors: indicators help assess health, predict trends, and guide decisions, improving timing and risk management.
27,651 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Two researchers are launching a dedicated effort to bring sustainability back into the AI conversation, promising mea...
Shares surged after quarterly results, lifting the outlook for this dividend-paying chip stock. Analysts say the stoc...
As AI enthusiasm cools, investors pivot to hard assets. New data show demand data center power rising faster than exp...
The Procure Space ETF (UFO) has surged as 2026 momentum builds in space-related stocks. This piece examines why the u...
As energy markets shift, investors must decide between EQT's pure-play gas model and Occidental's global oil mix. Thi...
Bank of America says Micron Technology is trading at a sub-10x forward multiple despite a structural shift toward AI-...
Investors are rethinking income strategies as inflation pressures linger and long-term payout growth demonstrates gre...
Explore an investor-friendly view of Privia Health as it heads into 2025. This original analysis covers growth driver...
BNO has jumped about 52% year-to-date, yet roll costs and futures contango are quietly eroding its gains. Here's what...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...